Gallium-67 as a tumor-seeking agent in lymphomas - A review

Annelies Draisma, Lorenzo Maffioli, Massimo Gasparini, Giordano Savelli, Ernest Pauwels, Emilio Bombardieri

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: At present 67Ga can be considered one of the most widely used viability radiotracers. There is general consensus in the literature that 67Ga has the highest clinical value in the management of lymphoma patients. Methods: We critically discuss the role of gallium scintigraphy in lymphoma patients on the basis of the experience of the Nuclear Medicine Division at the National Cancer Institute of Milan. Results and Conclusions: The sensitivity of gallium scan is very high (80-90%) in the staging and follow-up of Hodgkin's disease, and the method is also of great importance in the follow-up of lymphoma patients. We recommend scintigraphy to study the residual mediastinal mass after treatment. Our experiences during the follow- up of 189 lymphoma patients clearly showed the superior performance of gallium scan compared to MRI in the study of the mediastinal region after treatment. Sensitivity and specificity were both very high (90% and 96.9% vs 88.7% and 89.2%, respectively). Gallium scintigraphy can also be used to study the disease-free interval, post-treatment survival, early signs of recurrence and treatment response times. Comparison of the survival curves of 33 patients with diffuse large cell NonHodgkin's lymphoma examined at the National Cancer Institute showed a statistically significant difference (logrank test, P=0.0125) between patients with positive and those with negative gallium scan after 4-6 cycles of chemotherapy.

Original languageEnglish
Pages (from-to)434-441
Number of pages8
JournalTumori
Volume84
Issue number4
Publication statusPublished - Jul 1998

Fingerprint

Gallium
Lymphoma
Radionuclide Imaging
Neoplasms
National Cancer Institute (U.S.)
Cell Nucleus Division
Survival
Lymphoma, Large B-Cell, Diffuse
Nuclear Medicine
Therapeutics
Hodgkin Disease
Non-Hodgkin's Lymphoma
Reaction Time
Consensus
Recurrence
Drug Therapy
Sensitivity and Specificity

Keywords

  • Gallium scintigraphy
  • Lymphoma
  • Nuclear medicine techniques

ASJC Scopus subject areas

  • Cancer Research

Cite this

Draisma, A., Maffioli, L., Gasparini, M., Savelli, G., Pauwels, E., & Bombardieri, E. (1998). Gallium-67 as a tumor-seeking agent in lymphomas - A review. Tumori, 84(4), 434-441.

Gallium-67 as a tumor-seeking agent in lymphomas - A review. / Draisma, Annelies; Maffioli, Lorenzo; Gasparini, Massimo; Savelli, Giordano; Pauwels, Ernest; Bombardieri, Emilio.

In: Tumori, Vol. 84, No. 4, 07.1998, p. 434-441.

Research output: Contribution to journalArticle

Draisma, A, Maffioli, L, Gasparini, M, Savelli, G, Pauwels, E & Bombardieri, E 1998, 'Gallium-67 as a tumor-seeking agent in lymphomas - A review', Tumori, vol. 84, no. 4, pp. 434-441.
Draisma A, Maffioli L, Gasparini M, Savelli G, Pauwels E, Bombardieri E. Gallium-67 as a tumor-seeking agent in lymphomas - A review. Tumori. 1998 Jul;84(4):434-441.
Draisma, Annelies ; Maffioli, Lorenzo ; Gasparini, Massimo ; Savelli, Giordano ; Pauwels, Ernest ; Bombardieri, Emilio. / Gallium-67 as a tumor-seeking agent in lymphomas - A review. In: Tumori. 1998 ; Vol. 84, No. 4. pp. 434-441.
@article{ff97403d88a44fb693649f0bd12eeaf1,
title = "Gallium-67 as a tumor-seeking agent in lymphomas - A review",
abstract = "Background: At present 67Ga can be considered one of the most widely used viability radiotracers. There is general consensus in the literature that 67Ga has the highest clinical value in the management of lymphoma patients. Methods: We critically discuss the role of gallium scintigraphy in lymphoma patients on the basis of the experience of the Nuclear Medicine Division at the National Cancer Institute of Milan. Results and Conclusions: The sensitivity of gallium scan is very high (80-90{\%}) in the staging and follow-up of Hodgkin's disease, and the method is also of great importance in the follow-up of lymphoma patients. We recommend scintigraphy to study the residual mediastinal mass after treatment. Our experiences during the follow- up of 189 lymphoma patients clearly showed the superior performance of gallium scan compared to MRI in the study of the mediastinal region after treatment. Sensitivity and specificity were both very high (90{\%} and 96.9{\%} vs 88.7{\%} and 89.2{\%}, respectively). Gallium scintigraphy can also be used to study the disease-free interval, post-treatment survival, early signs of recurrence and treatment response times. Comparison of the survival curves of 33 patients with diffuse large cell NonHodgkin's lymphoma examined at the National Cancer Institute showed a statistically significant difference (logrank test, P=0.0125) between patients with positive and those with negative gallium scan after 4-6 cycles of chemotherapy.",
keywords = "Gallium scintigraphy, Lymphoma, Nuclear medicine techniques",
author = "Annelies Draisma and Lorenzo Maffioli and Massimo Gasparini and Giordano Savelli and Ernest Pauwels and Emilio Bombardieri",
year = "1998",
month = "7",
language = "English",
volume = "84",
pages = "434--441",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Gallium-67 as a tumor-seeking agent in lymphomas - A review

AU - Draisma, Annelies

AU - Maffioli, Lorenzo

AU - Gasparini, Massimo

AU - Savelli, Giordano

AU - Pauwels, Ernest

AU - Bombardieri, Emilio

PY - 1998/7

Y1 - 1998/7

N2 - Background: At present 67Ga can be considered one of the most widely used viability radiotracers. There is general consensus in the literature that 67Ga has the highest clinical value in the management of lymphoma patients. Methods: We critically discuss the role of gallium scintigraphy in lymphoma patients on the basis of the experience of the Nuclear Medicine Division at the National Cancer Institute of Milan. Results and Conclusions: The sensitivity of gallium scan is very high (80-90%) in the staging and follow-up of Hodgkin's disease, and the method is also of great importance in the follow-up of lymphoma patients. We recommend scintigraphy to study the residual mediastinal mass after treatment. Our experiences during the follow- up of 189 lymphoma patients clearly showed the superior performance of gallium scan compared to MRI in the study of the mediastinal region after treatment. Sensitivity and specificity were both very high (90% and 96.9% vs 88.7% and 89.2%, respectively). Gallium scintigraphy can also be used to study the disease-free interval, post-treatment survival, early signs of recurrence and treatment response times. Comparison of the survival curves of 33 patients with diffuse large cell NonHodgkin's lymphoma examined at the National Cancer Institute showed a statistically significant difference (logrank test, P=0.0125) between patients with positive and those with negative gallium scan after 4-6 cycles of chemotherapy.

AB - Background: At present 67Ga can be considered one of the most widely used viability radiotracers. There is general consensus in the literature that 67Ga has the highest clinical value in the management of lymphoma patients. Methods: We critically discuss the role of gallium scintigraphy in lymphoma patients on the basis of the experience of the Nuclear Medicine Division at the National Cancer Institute of Milan. Results and Conclusions: The sensitivity of gallium scan is very high (80-90%) in the staging and follow-up of Hodgkin's disease, and the method is also of great importance in the follow-up of lymphoma patients. We recommend scintigraphy to study the residual mediastinal mass after treatment. Our experiences during the follow- up of 189 lymphoma patients clearly showed the superior performance of gallium scan compared to MRI in the study of the mediastinal region after treatment. Sensitivity and specificity were both very high (90% and 96.9% vs 88.7% and 89.2%, respectively). Gallium scintigraphy can also be used to study the disease-free interval, post-treatment survival, early signs of recurrence and treatment response times. Comparison of the survival curves of 33 patients with diffuse large cell NonHodgkin's lymphoma examined at the National Cancer Institute showed a statistically significant difference (logrank test, P=0.0125) between patients with positive and those with negative gallium scan after 4-6 cycles of chemotherapy.

KW - Gallium scintigraphy

KW - Lymphoma

KW - Nuclear medicine techniques

UR - http://www.scopus.com/inward/record.url?scp=0031725916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031725916&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 434

EP - 441

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4

ER -